1. Covidien kicks off PAD studies in Europe

    Covidien said its Definitive AR anti-restenosis study is enrolling patients at Imelda Hospital in Bonheiden, Belgium. Definitive AR is a pilot study designed to address restenosis, which is the narrowing of a blood vessel in patients with PAD, and will look at the impact of treating a diseased vessel with plaque excision prior to the use of a drug-coated balloon. The study will focus on whether removing calcified plaque will enhance the absorption of drugs delivered by a drug-coated balloon.
    Read Full Article

    Login to comment.

  1. Categories

    1. Industry Clusters:

      Aerospace/Defense, Business Development, Creative Economy, Education, Energy, Entrepreneurship, Financial Services, Green Region, Health Care, Information Technology, Life Sciences, Logistics, Manufacturing, Medical Devices, Paper Manufacturing, Plastics, Retail, Tourism, Transportation, Workforce
  2. Topics Mentioned

  3. Authors